Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,109.14
(
-0.24%
)
US TECH 100
25,861.20
(
-0.36%
)
Dow Jones
49,442.56
(
-0.01%
)
Brent Oil
91.40
(
-1.36%
)
Bitcoin
76,281.50
(
3.28%
)
News Focus
News Focus
Post# of 517454
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Hoskuld

Send PM Follow Ignore
Followers 35
Posts 4005
Boards Moderated 0
Alias Born 08/07/2022

Hoskuld

Re: Molleone post# 500671

Tuesday, 09/16/2025 7:30:48 AM

Tuesday, September 16, 2025 7:30:48 AM

Post# of 517454
Molleone, there is no way that the stock price can be controlled to prevent significant appreciation subsequent to EMA approval of blarcasemine. Maybe the extent of that appreciation can be controlled. But there is no way that tier one pharma companies will not be lining up to partner with or buy Anavex upon that event.

This narrative that approval will be irrelevant to the share price is now being pushed by a few people here. Interesting.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News